BioCardia Inc

Company Profile

BioCardia Inc had its IPO on 2019-08-02 under the ticker symbol BCDAW.

The company operates in the Other sector and Other industry. BioCardia Inc has a staff strength of 27 employees.

Stock update

Shares of BioCardia Inc opened at $0.44 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.44 - $0.44, and closed at $0.44.

This is a +69.75% increase from the previous day's closing price.

A total volume of 202 shares were traded at the close of the day’s session.

In the last one week, shares of BioCardia Inc have slipped by -42.25%.

BioCardia Inc's Key Ratios

BioCardia Inc has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months BioCardia Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures BioCardia Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BioCardia Inc’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, BioCardia Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

BioCardia Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BioCardia Inc’s profitability.

BioCardia Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

BioCardia Inc stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$7.13 million

Total Liabilities

$4.00 million

Operating Cash Flow

$0

Capital Expenditure

$10000

Dividend Payout Ratio

0%

BioCardia Inc ended 2024 with $7.13 million in total assets and $0 in total liabilities. Its intangible assets were valued at $7.13 million while shareholder equity stood at $1.90 million.

BioCardia Inc ended 2024 with $0 in deferred long-term liabilities, $4.00 million in other current liabilities, 20000.00 in common stock, $-144105000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $4.86 million and cash and short-term investments were $4.86 million. The company’s total short-term debt was $327,000 while long-term debt stood at $0.

BioCardia Inc’s total current assets stands at $5.29 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $153000.00 compared to accounts payable of $861000.00 and inventory worth $0.

In 2024, BioCardia Inc's operating cash flow was $0 while its capital expenditure stood at $10000.

Comparatively, BioCardia Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.44

52-Week High

$1.74

52-Week Low

$0.064

Analyst Target Price

$

BioCardia Inc stock is currently trading at $0.44 per share. It touched a 52-week high of $1.74 and a 52-week low of $1.74. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.73 and 200-day moving average was $0.64 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.